Allied Academies
0 days
0 hours
0 minutes
0 seconds

Track 19: Obesity, Metabolic Syndrome, and Gastrointestinal Impact

Track 19: Obesity, Metabolic Syndrome, and Gastrointestinal Impact

Obesity and metabolic syndrome negatively affect gastrointestinal health, increasing the risk of conditions like GERD, fatty liver disease, and gallstones. Metabolic syndrome, with features like obesity and insulin resistance, heightens the risk of NAFLD and other liver diseases. Excess fat accumulation can cause inflammation in the GI tract, affecting digestion and gut motility. Obesity also complicates the management of inflammatory bowel disease (IBD) and other GI disorders.

Sub Tracks:

  • Obesity and GI Disorders
     
  • GERD and Obesity
     
  • Non-Alcoholic Fatty Liver Disease (NAFLD)
     
  • Gallstones and Obesity
     
  • Metabolic Syndrome and Digestive Health
     
  • Inflammatory Bowel Disease (IBD) and Obesity

Previous Conferences

Special Issues

All accepted abstracts will be published in respective Allied Academies Journals.

Abstracts will be provided with Digital Object Identifier by

Special Issues
Copyright © 2025 Allied Academies, All Rights Reserved.